home / stock / igc / igc news


IGC News and Press, India Globalization Capital Inc. From 06/23/22

Stock Information

Company Name: India Globalization Capital Inc.
Stock Symbol: IGC
Market: NYSE
Website: igcinc.us

Menu

IGC IGC Quote IGC Short IGC News IGC Articles IGC Message Board
Get IGC Alerts

News, Short Squeeze, Breakout and More Instantly...

IGC - IGC Makes Progress on THC For Alzheimer's

India Globalization Capital, Inc. (IGC) (NYSE: IGC) announces its financial results for the fiscal year ending March 31, 2022. IGC reported that its revenue was approximately $397 thousand and $898 thousand for Fiscal 2022 and Fiscal 2021, respectively. The net loss for Fi...

IGC - India Globalization Capital GAAP EPS of -$0.30, revenue of $0.4M

India Globalization Capital press release (NYSE:IGC): FY GAAP EPS of -$0.30. Revenue of $0.4M (-55.6% Y/Y). For further details see: India Globalization Capital GAAP EPS of -$0.30, revenue of $0.4M

IGC - IGC Reports Financial Results for Fiscal Year Ended March 31, 2022

India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces its financial results for Fiscal Year Ended March 31, 2022. Highlights for Fiscal 2022: IGC completed the first-in-human safety and tolerability trial on i...

IGC - India Globalization stock rises 10% on acquiring rights for potential Alzheimer's drug compound

India Globalization Capital (NYSE:IGC) said it acquired exclusive global rights to a potential Alzheimer’s drug development candidate TGR-63 from India-based Jawaharlal Nehru Centre for Advanced Scientific Research. The company said JNCASR has developed Naphtha...

IGC - IGC Acquires Exclusive Rights for a Potential Alzheimer's Drug Development Candidate

India Globalization Capital, Inc. (NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer’s drug development candidate. Researchers at the Jawaharlal Nehru Centre for Advanced Scientific...

IGC - IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders

India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that the United States Patent and Trademark Office (“USPTO”) issued a patent (#11,351,152) to the Company titled “Method and Composition for Treating Seizure Disorde...

IGC - India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors

India Globalization Capital, Inc. (NYSE American: IGC) announces that the Board has appointed Ms. Claudia Grimaldi as a non-independent Director, effective March 23, 2022. IGC now has 5 directors including a majority who are independent. Ms. Grimaldi has been with IGC for almost 12 ...

IGC - India Globalization Capital GAAP EPS of -$0.05, revenue of $0.14M

India Globalization Capital press release (NYSE:IGC): Q4 GAAP EPS of -$0.05. Revenue of $0.14M (+27.3% Y/Y). For further details see: India Globalization Capital GAAP EPS of -$0.05, revenue of $0.14M

IGC - IGC Reports Financial Results for the December 31, 2021 Quarter

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the three months ending December 31, 2021 – quarter three of the Company’s 2022 fiscal year. Highlights include: The Company appointed former congressman James Moran to its...

IGC - India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors

India Globalization Capital, Inc. (NYSE American: IGC) is excited to announce that the Board has appointed former Congressman Jim Moran (“Congressman Moran”) as an independent Director. IGC is delighted to welcome Congressman Moran to its Board of Directors. Congressma...

Previous 10 Next 10